Home | American Pharmacists Association

News View all news

July 23, 2019

FDA approves first generics of pregabalin

FDA announced Monday that it has approved nine applications for the generic versions of pregabalin (Lyrica—Pfizer) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients aged 17 years a

July 22, 2019

Court filings say corporations fed opioid epidemic

Cities, towns, and counties on Friday filed thousands of documents from corporations across the pharmaceutical supply chain as they laid out a detailed case of how diverse interests fed an opioid epidemic that persisted for nearly 2 decades.

July 19, 2019

AMA Opioid Task Force releases recommendations to increase treatment access

The American Medical Association (AMA) is asking state and federal authorities to step in to help eliminate the current barriers that prevent so many patients with opioid use disorder from receiving appropriate treatment.

July 19, 2019

A peek into safe use of essential oils

Essential oils have soared in popularity. Here is a primer to help you guide your patients in their safe use.

July 19, 2019

Second opioid distributor charged over role in U.S. drug epidemic

Federal officials said Thursday that Miami-Luken, an Ohio drug wholesale distributor, and two of its former executives have been charged for their roles in the U.S. opioid crisis.

Students

Let APhA help you through your pharmacy training and beyond.

Learn More

New Practitioners

Your career starts here. Get the tools you need to kick-start your career.

Learn More

Pharmacists

Reach your full potential as a pharmacist with these helpful practice tools and resources.

Learn More

Pharmacy Technicians

Media/Press

Not a member? See What APhA can do for you

CEO Blog

by Thomas E. Menighan

View all CEO blog posts

July 16, 2019

Chapter Three: Behind the emotions

Note from Tom: The following is the third edition of APhA President Brad Tice's monthly guest blog.June was a month filled with the first APhA Board meeting of my presidency year; opportunities to…

Support for all the hurting pharmacists and the fight for a…

Today we offer our support to the many pharmacists who have been affected by layoffs or practice constrictions, as well as those of you whose job searches and practice changes have gotten even more…

Press Releases

View all press releases

July 16, 2019

APhA Launches New Well-Being Tool to Evaluate Pharmacists’ Stress, Burnout Levels

The American Pharmacists Association (APhA) has announced that it is launching the Well-Being Index, a validated screening tool invented by the Mayo Clinic to evaluate fatigue, depression, burnout, anxiety/stress, and mental/physical quality of life. The Well-Being Index represents one of the many efforts APhA has undertaken in its commitment to address pharmacist burnout and pave the way for real opportunities to improve the well-being and resiliency of pharmacists and pharmacy personnel.

July 11, 2019

Former APhA President Janet Engle Named ACPE Executive Director

The American Pharmacists Association (APhA) congratulates Janet P. Engle, PharmD, PhD (Hon), FAPhA, FCCP, FNAP, on being named the new Executive Director of the Accreditation Council for Pharmacy Education. ACPE announced today that Dr. Engle will begin her new leadership role in September 2019.

Why APhA?

APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.